PM360

APRIL 22, 2024

With a focus on patient-centricity, data-driven insights, and collaborative partnerships across the healthcare ecosystem, it’s redefining the playbook for market shaping and building advocacy for a product pre- and post-launch. Medical Affairs is at the forefront of this paradigm shift.

Medical 52

Medical Healthcare Healthcare Education 52

Clarify Health

NOVEMBER 22, 2023

Today’s healthcare providers are seeing significantly more patients than they did a decade ago – many of whom are often sicker and have more complex care needs. These patients have evolving and growing needs and expectations for the quality of care delivered and overall patient experience.

Leads 52

Leads Healthcare Healthcare Patients 52

Pharmaceutical Technology

JULY 14, 2022

Historically, the pharmaceutical industry has failed to meet the needs of this patient population. Most famously, the US passed its Orphan Drug Act in 1983, providing innovators with financial motivation to develop orphan drugs and meet the needs of these forgotten patients. Efforts have been made to change this.

Medicine 59

Medicine Marketing Specialization Pharma 59

Pharmaceutical Technology

MAY 1, 2023

CTH-004 is developed by genetically altering patient T cells for inserting a chimeric antigen receptor (CAR) to target a marker (TAG-72) on ovarian cancer cells and delete genes which are involved in T cell function suppression. Shunxi will also hold an option to negotiate rights to other CAR-T products, which include the licenced IP.

Manufacturing 52

Manufacturing Patients Leads Pharmaceutical 52

PM360

NOVEMBER 12, 2023

And how can they determine what data will lead to the most meaningful change for their campaigns, healthcare professionals (HCPs), and ultimately patients? And how can they determine what data will lead to the most meaningful change for their campaigns, healthcare professionals (HCPs), and ultimately patients?

Marketing 59

Marketing Media Patients Healthcare 59

European Pharmaceutical Review

AUGUST 24, 2022

To engineer an ideal ADC, the drug must achieve a cohesive, molecular partnership between the cellular target, antibody, cytotoxic payload and chemical linker. ANTIBODY-DRUG conjugates (ADCs) are therapeutic molecules designed as highly targeted medicines with the promise of changing the way we treat cancer and other diseases.

Engineering 93

Engineering Side effects Marketing Patients 93

PM360

SEPTEMBER 7, 2023

The “Kama Sutra” for Parkinson’s patients. A card game designed to help hemophilia patients exercise. A virtual product launch for patients akin to an iPhone debut. All of these are examples of how companies are taking a little more unconventional approach to patient engagement. Marketing and Patient Engagement, argenx.

Patients 105

Patients Pharma Education Doctors 105